Migraine and MTHFR C677T genotype in a population-based sample

Annals of Neurology

Volumn 59, Issue 2, 2006, Pages 372-375

  Scher, Ann I ^a,b   Terwindt, Gisela M ^c   Verschuren, W M Monique ^d   Kruit, Mark C ^c   Blom, Henk J ^e   Kowa, Hisanori ^f   Frants, Rune R ^c   Van Den Maagdenberg, Arn M J M ^c   Van Buchem, Mark ^c   Ferrari, Michel D ^c   Launer, Lenore J ^b,d  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^f TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CHOLESTEROL; CYANOCOBALAMIN; FOLIC ACID; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHROMOSOME 1P; CONFIDENCE INTERVAL; FEMALE; GENE FREQUENCY; GENETIC EPIDEMIOLOGY; GENETIC POLYMORPHISM; GENOTYPE; HOMOCYSTEINE BLOOD LEVEL; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NETHERLANDS; ONSET AGE; POPULATION RESEARCH; PRIORITY JOURNAL; SOCIAL STATUS; STATISTICAL ANALYSIS; STROKE; VITAMIN BLOOD LEVEL; WILD TYPE;

ADULT; AGED; CARBON-NITROGEN LIGASES; COMMUNITY HEALTH PLANNING; CONFIDENCE INTERVALS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS; SEX FACTORS;

EID: 32044450821     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20755     Document Type: Article

References (20)

1. Swartz RH, Kern RZ. Migraine is associated with magnetic resonance imaging white matter abnormalities: a meta-analysis. Arch Neurol 2004;61:1366-1368.
2. Kruit MC, van Buchem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004;291:427-434.
3. Scher AI, Terwindt GM, Picavet HSJ, et al. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology 2005;64:614-620.
4. De Bree A, Verschuren WM, Kromhout D, et al. Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease. Pharmacol Rev 2002;54:599-618.
5. Hobbs CA, Cleves MA, Melnyk S, et al. Congenital heart defects and abnormal maternal biomarkers of methionine and homocysteine metabolism. Am J Clin Nutr 2005;81:147-153.
6. de Bree A, Verschuren WM, Bjorke-Monsen AL, et al. Effect of the methylenetetrahydrofolate reductase 677C→T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample. Am J Clin Nutr 2003;77:687-693.
7. Kowa H, Yasui K, Takeshima T, et al. The homozygous C677T mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for migraine. Am J Med Genet 2000;96:762-764.
8. Lea RA, Ovcaric M, Sundholm J, et al. The methylenetetrahydrofolate reductase gene variant C677T influences susceptibility to migraine with aura. BMC Med 2004;2:3.
9. Kara I, Sazci A, Ergul E, et al. Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk. Brain Res Mol Brain Res 2003;111:84-90.
10. Oterino A, Valle N, Bravo Y, et al. MTHFR T677 homozygosis influences the presence of aura in migraineurs. Cephalalgia 2004;24:491-494.
11. Picavet HS, Schouten JS, Smit HA. Prevalence and consequences of low back problems in the Netherlands, working vs non-working population, the MORGEN-Study. Monitoring Project on Risk Factors for Chronic Disease. Public Health 1999;113:73-77.
12. Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology 1999;53:537-542.
13. Terwindt GM, Ferrari MD, Tijhuis M, et al. The impact of migraine on quality of life in the general population: the GEM study. Neurology 2000;55:624-629.
14. Botto LD, Yang Q. 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 2000;151:862-877.
15. Hering-Hanit R, Gadoth N, Yavetz A, et al. Is blood homocysteine elevated in migraine? Headache 2001;41:779-781.
16. Evers, S, Koch HG, Suhr B, Husstedt IW. Increased homocysteine level in migraine with aura. Eur J Neurol 1998;5(suppl 3):S51-S52.
17. D'Amico D, Moschiano F, Attanasio A, et al. Hyperhomocysteinemia in patients with migraine with aura. Cephalalgia 2003;23:742.
18. Dreier JP, Kleeberg J, Petzold G, et al. Endothelin-1 potently induces Leao's cortical spreading depression in vivo in the rat: a model for an endothelial trigger of migrainous aura? Brain 2002;125:102-112.
19. Splaver A, Lamas GA, Hennekens CH. Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials. Am Heart J 2004;148:34-40.
20. Hadjikhani N, Sanchez dR, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 2001;98:4687-4692.